Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Byrd

Showing results (881-890 of 903) with videos related to

Pageof 91
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|June 14, 2014
Non-Hodgkin's lymphomas, version 2.2014Andrew D Zelenetz, Leo I Gordon, William G Wierda, et al.
Cancer Research|January 24, 2014
Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastomaFengting Yan, Lapo Alinari, Mark E Lustberg, et al.
Haematologica|November 6, 2025
<i>IDH2</i> mutation is associated with favorable outcome among older adults with newly diagnosed acute myeloid leukemia treated with hypomethylating agent-based therapyFieke W Hoff, Ying Huang, Rina Li Welkie, et al.
Blood|October 26, 2016
Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphomaZijun Y Xu-Monette, Ling Li, John C Byrd, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2014
Non-Hodgkin's lymphomas, version 4.2014Andrew D Zelenetz, Leo I Gordon, William G Wierda, et al.
Leukemia|September 19, 2025
Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology)Monica Cusan, Karilyn Larkin, Deedra Nicolet, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 5, 2015
Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015Andrew D Zelenetz, Leo I Gordon, William G Wierda, et al.
Nature Medicine|October 27, 2020
Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master TrialAmy Burd, Ross L Levine, Amy S Ruppert, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2013
Genetic heterogeneity of diffuse large B-cell lymphomaJenny Zhang, Vladimir Grubor, Cassandra L Love, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2016
Diffuse Large B-Cell Lymphoma Version 1.2016Andrew D Zelenetz, Leo I Gordon, William G Wierda, et al.
Pageof 91

Showing results (881-890 of 903) with videos related to

Sort By:
Pageof 91
Journal of the National Comprehensive Cancer Network : JNCCN|June 14, 2014
Non-Hodgkin's lymphomas, version 2.2014Andrew D Zelenetz, Leo I Gordon, William G Wierda, et al.
Cancer Research|January 24, 2014
Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastomaFengting Yan, Lapo Alinari, Mark E Lustberg, et al.
Haematologica|November 6, 2025
<i>IDH2</i> mutation is associated with favorable outcome among older adults with newly diagnosed acute myeloid leukemia treated with hypomethylating agent-based therapyFieke W Hoff, Ying Huang, Rina Li Welkie, et al.
Blood|October 26, 2016
Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphomaZijun Y Xu-Monette, Ling Li, John C Byrd, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2014
Non-Hodgkin's lymphomas, version 4.2014Andrew D Zelenetz, Leo I Gordon, William G Wierda, et al.
Leukemia|September 19, 2025
Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology)Monica Cusan, Karilyn Larkin, Deedra Nicolet, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 5, 2015
Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015Andrew D Zelenetz, Leo I Gordon, William G Wierda, et al.
Nature Medicine|October 27, 2020
Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master TrialAmy Burd, Ross L Levine, Amy S Ruppert, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2013
Genetic heterogeneity of diffuse large B-cell lymphomaJenny Zhang, Vladimir Grubor, Cassandra L Love, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2016
Diffuse Large B-Cell Lymphoma Version 1.2016Andrew D Zelenetz, Leo I Gordon, William G Wierda, et al.
Pageof 91